Detalles de la búsqueda
1.
The Presence of (1â3)-ß-D-Glucan as Prognostic Marker in Patients After Major Abdominal Surgery.
Clin Infect Dis
; 73(7): e1415-e1422, 2021 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914187
2.
Predicting Invasive Aspergillosis in Hematology Patients by Combining Clinical and Genetic Risk Factors with Early Diagnostic Biomarkers.
J Clin Microbiol
; 56(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29118175
3.
Boswellia frereana suppresses HGF-mediated breast cancer cell invasion and migration through inhibition of c-Met signalling.
J Transl Med
; 16(1): 281, 2018 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30314527
4.
Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis.
J Clin Microbiol
; 51(5): 1510-6, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23486712
5.
Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
J Cell Physiol
; 216(3): 780-9, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18449907
6.
Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients.
Clin Cancer Res
; 13(12): 3568-76, 2007 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17575220
7.
Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro.
Int J Mol Med
; 20(4): 613-9, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17786295
8.
Decreased pigment epithelium-derived factor expression in human breast cancer progression.
Clin Cancer Res
; 12(11 Pt 1): 3510-7, 2006 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16740777
9.
Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo.
J Exp Ther Oncol
; 6(1): 39-48, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17228523
10.
Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.
Int J Mol Med
; 17(4): 583-90, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16525713
11.
Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.
Clin Cancer Res
; 11(16): 6012-9, 2005 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16115946
12.
Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer.
Breast Cancer Res
; 7(4): R402-10, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15987445
13.
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.
Crit Rev Oncol Hematol
; 53(1): 35-69, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15607934
14.
Placenta growth factor is over-expressed and has prognostic value in human breast cancer.
Eur J Cancer
; 41(18): 2819-27, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16275058
15.
The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
Int J Mol Med
; 16(4): 723-8, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16142411
16.
The hepatocyte growth factor regulatory factors in human breast cancer.
Clin Cancer Res
; 10(1 Pt 1): 202-11, 2004 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14734471
17.
Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET.
Clin Cancer Res
; 9(11): 4274-81, 2003 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14519655
18.
Upregulation of tumour endothelial marker-8 by interleukin-1beta and its impact in IL-1beta induced angiogenesis.
Int J Mol Med
; 14(1): 75-80, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15202019
19.
Hepatocyte growth factor activation inhibitors - therapeutic potential in cancer.
Anticancer Agents Med Chem
; 10(1): 47-57, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20015004
20.
The type II transmembrane serine protease, matriptase-2: Possible links to cancer?
Anticancer Agents Med Chem
; 10(1): 64-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20015002